CDK-IN-14
CDK-IN-14 (B34) is a potent and selective CDK2 inhibitor (IC50=0.097 μM) with demonstrated anti-hepatocellular carcinoma activity. In vitro, it induces cell cycle arrest and caspase-mediated apoptosis in HepG-2 cells, supporting its use in oncology research focused on cell cycle regulation and apoptosis mechanisms.
Product Specifications
Field of Research
Cell Biology, Protein Biochemistry
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CK97-500ug 500 µg
Recombinant Mouse Cadherin-3/P-Cadherin/CDH3 (C-Fc)
Sign In for Pricing
View Details GTR15219265 1 Vial
Lentiviral mouse Ifnl3 shRNA (UAS) - Lentiviral mouse Ifnl3 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details MBS8820997-01 48 Well
Human IFIT-1 (Interferon-induced protein with tetratricopeptide repeats 1) ELISA Kit
Sign In for Pricing
View Details